Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
about
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyA systematic review of lessons learned from PET molecular imaging research in atypical parkinsonismDisease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus ScaleMesenchymal stem cells can modulate longitudinal changes in cortical thickness and its related cognitive decline in patients with multiple system atrophy.Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group.18F-fluorodeoxyglucose positron emission tomography/computed tomography in a case of non-ketotic hyperglycemiaThe Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System Atrophy.Network correlates of disease severity in multiple system atrophy.Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.Different subregional metabolism patterns in patients with cerebellar ataxia by 18F-fluorodeoxyglucose positron emission tomographyExpanding the spectrum of neuronal pathology in multiple system atrophy.Consensus paper: radiological biomarkers of cerebellar diseasesAltered Functional and Causal Connectivity of Cerebello-Cortical Circuits between Multiple System Atrophy (Parkinsonian Type) and Parkinson's Disease.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.Cognitive impairment in multiple system atrophy.Potential clinical utility of multiple system atrophy biomarkers.Brain structural profile of multiple system atrophy patients with cognitive impairment.Cognitive impairment before changes appear on [18F]-fluoro-D-glucose positron emission tomography images in a patient with possible early-stage cerebellar-predominant multiple system atrophy.Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy.A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Niccolini and Politis, 2016) : Reply to Jean-Claude Baron Letter to Editor.Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study.Cognitive impairments associated with morphological changes in cortical and subcortical structures in multiple system atrophy of the cerebellar type.Different loss of dopamine transporter according to subtype of multiple system atrophy.[Differential diagnostics of Parkinson's disease with nuclear medicine procedures].Progression of striatal and extrastriatal degeneration in multiple system atrophy: A longitudinal diffusion-weighted MR study
P2860
Q24655620-66FD1149-303A-4000-B4E0-302008E574E7Q28075227-B8AD0449-5DA0-4EEC-AA20-3139B6C6E1A9Q28741794-77890CF0-4432-4750-8457-6900B3FAEB5EQ33750881-3804A427-D565-4A6C-B154-1FC867B1D843Q34245237-36252E61-7C2B-4C3A-85F8-439CBCDBDEF0Q34494708-F1ACF087-6F4E-441A-8CBD-875D76E695D8Q35797271-E1E34983-C3FF-4F22-AEAD-BD150EC02FD7Q35883193-71F01937-E639-45CC-9CE1-27F61DF704D6Q36248897-D685B718-D62C-4506-8505-73631A9C233CQ36314634-C23CF95D-EBC1-4744-BC0C-789F4C51367BQ36825501-E752FA40-3111-479D-B6D1-D08BC66BE1EEQ37058210-202B78BD-248A-4811-8C36-C037782AD835Q38604924-68C1015F-65AE-45B1-970A-BB67FD0A0D56Q38669105-69B60C47-F193-477E-9975-1802F7475E82Q38896237-F56E2336-68AA-467B-8D0E-783A9642343DQ39410903-8DB99FF9-4EE1-43BF-9F2D-F92E44E6A333Q47663712-72C7D9A8-EBD2-4F63-BAE9-6E50EB793502Q47902364-C446E554-33BF-4532-B598-5862925557CEQ47961037-707D588C-9F14-414F-95C5-18803D8C40C9Q49562668-CC7B43EF-283C-41FB-BC15-C085F83F157DQ50466636-4533E4E2-AB49-46D8-A45E-8F87445D55DAQ50640064-C12C2AF6-30AB-4A98-9883-E15D98799ED4Q51824828-B75BB4C1-447C-474F-A59A-D6F01E5D15F2Q52149073-F77D44E4-330B-46F0-BDCF-8CF1BCA7BE22Q53066302-D4B29CE4-1DE9-4861-AA21-E914FC9C094CQ57269622-4344899A-DF4E-4903-90D8-FBB0E3C2C1D9
P2860
Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effects of disease duration on ...... type multiple system atrophy.
@en
Effects of disease duration on ...... type multiple system atrophy.
@nl
type
label
Effects of disease duration on ...... type multiple system atrophy.
@en
Effects of disease duration on ...... type multiple system atrophy.
@nl
prefLabel
Effects of disease duration on ...... type multiple system atrophy.
@en
Effects of disease duration on ...... type multiple system atrophy.
@nl
P2093
P50
P356
P1433
P1476
Effects of disease duration on ...... d type multiple system atrophy
@en
P2093
P304
P356
10.1093/BRAIN/AWM328
P407
P577
2008-01-04T00:00:00Z